Kyorin Pharma

News

Kyorin Pharma has signed a deal with Hyfe to develop a digital therapeutic (DTx) for people with chronic cough and launch it in Japan.

News

A failed phase 2 study has undermined Novartis' hopes of extending the approved indications for Fabhalta to include lupus nephritis.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.